Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Karina Dalsgaard Sørensen

Aarhus University

Denmark

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Biostatistics

70%

Cell Biology

30%

Cancer Biology

80%

Prostate Cancer

60%

Transcriptomic

30%

Medical Science

20%

Pharmacogenomic

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles20

Development and retrospective validation of an artificial intelligence system for diagnostic assessment of prostate biopsies

Article Link

Year:

2025

Physical Color Calibration of Digital Pathology Scanners for Robust Artificial Intelligence-Assisted Cancer Diagnosis.

Article Link

Year:

2025

Deep targeted sequencing of circulating tumor DNA to inform treatment in patients with metastatic castration-resistant prostate cancer

Article Link

Year:

2025

Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.

Article Link

Year:

2024

Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk

Article Link

Year:

2024

A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer

Article Link

Year:

2024

Highly sensitive deep panel sequencing of 27 HPV genotypes in prostate cancer biopsies results in very low detection rates and indicates that HPV is not a major etiological driver of this malignancy

Article Link

Year:

2024

Liquid-Biopsy Glycan Score Biomarker Accurately Indicates and Stratifies Primary and Metastatic Prostate Cancers

Article Link

Year:

2024

Exploring the tumor genomic landscape of aggressive prostate cancer by whole-genome sequencing of tissue or liquid biopsies

Article Link

Year:

2024

Germline sequencing in men with metastatic castration-resistant prostate cancer from the BARCODE2 study reveals a wide range of pathogenic variants in DNA repair genes

Article Link

Year:

2024

Spatial profiling of circular RNAs in cancer reveals high expression in muscle and stromal cells

Article Link

Year:

2023

Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.

Article Link

Year:

2023

Results from the PRIMA Trial: Comparison of the STHLM3 Test and Prostate-specific Antigen in General Practice for Detection of Prostate Cancer in a Biopsy-naïve Population

Article Link

Year:

2023

Prognostic Value of Low-Pass Whole Genome Sequencing of Circulating Tumor DNA in Metastatic Castration-Resistant Prostate Cancer

Article Link

Year:

2023

Spatial whole transcriptome profiling of primary tumor from patients with metastatic prostate cancer

Article Link

Year:

2023

Genetically proxied glucose-lowering drug target perturbation and risk of cancer

Article Link

Year:

2023

Investigation of enzalutamide, docetaxel, and cabazitaxel resistance in the castration resistant prostate cancer cell line C4 using genome-wide CRISPR/Cas9 screening

Article Link

Year:

2023

Cost-Effectiveness Analysis of Stockholm 3 Testing Compared to PSA as the Primary Blood Test in the Prostate Cancer Diagnostic Pathway

Article Link

Year:

2022

Microbiota of the prostate tumor environment investigated by whole-transcriptome profiling

Article Link

Year:

2022

Identification of a high-risk immunogenic prostate cancer patient subset as candidates for T-cell engager immunotherapy and the introduction of a novel albumin-fused anti-CD3 × anti-PSMA bispecific design

Article Link

Year:

2022

Collaborators33

Kjell Grankvist

Full Professor/Senior Consultant

Umeå Universitet

SWEDEN

Jakob S Pedersen

Aarhus University

DENMARK

Jakob Hansen Haldrup

University of Oxford

UNITED KINGDOM

Pedersen Bodil Ginnerup

Aarhus University

DENMARK

Svein Reidar Kjosavik

Associated professor

University of Bergen

NORWAY

Jørgen Bjerggaard Jensen

Aarhus University

DENMARK

Lars Dyrskjøt

Aarhus University Hospital

DENMARK

Jacob Fredsøe

Aarhus University

DENMARK

Jorgen Kjems

Aarhus University

DENMARK

Johan Lindberg

Karolinska University Hospital

SWEDEN

Kimmo Kartasalo

Karolinska Institutet

SWEDEN

Yong-Jie Lu

Professor in Molecular Oncology

Queen Mary University of London

UNITED KINGDOM

Bettina Risør

Aalborg University

DENMARK

Juan Luis García-Rodríguez

Aarhus University

DENMARK

Kenneth Howard

Associate Professor

Aarhus University

DENMARK

John Field

Clinical Professor of Molecular Oncology

UNITED KINGDOM

Kristina Hotakainen

University of Helsinki

FINLAND

Ruth Travis

Professor of Epidemiology

University of Oxford

UNITED KINGDOM

Manuel António Rodrigues Teixeira

Guest Full Professor

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar

PORTUGAL

Rosalind Eeles

Professor of Oncogenetics (Since 2010) & Honorary Consultant in Clinical Oncology & Cancer Genetics (Since 1994)

The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust

UNITED KINGDOM

Hannu Koistinen

University of Helsinki

FINLAND

Burcu F Darst

UNITED STATES

Elizabeth Bancroft

Chief Nurse, NT GMSA

Great Ormond Street Institute of Child Health

UNITED KINGDOM

Davor Lessel

University Medical Center Hamburg-Eppendorf

GERMANY

Joan Röhl

Assistant Professor

Bond University

AUSTRALIA

Lasse Sommer Kristensen

Aarhus University

DENMARK

Torben Steiniche

Aarhus University

DENMARK

Magnus Stougaard

Aarhus University

DENMARK

Morten T. Jarlstad Olesen

Aarhus University

DENMARK

Søren Vang

DVIP-external, Head of Clinical Bioinformatics

Aarhus University

DENMARK

Olympia Dimopoulou

University of Bristol

UNITED KINGDOM

Paul vinu Salachan

Aarhus University

DENMARK

Marcin Braun

Medical University of Lodz

POLAND

How do I reach out?

Meet Kite AI